Author: AEYE Health

AEYE-DS Clinical Trials Published: First Fully Autonomous Diabetic Retinopathy Screening Technology Across Portable and Tabletop Devices Demonstrates 99% Imageability, One-Image-per-Eye Workflow, and Best-in-Class Diagnostic Efficacy

September 9, 2026
New Real-World Data Shows AEYE-DS Autonomous AI Achieving a 96% Success Rate (Imageability) Without Dilation in a High-Traffic Endocrinology Clinic

August 4, 2026

AEYE-DS Clinical Trials Published: First Fully Autonomous Diabetic Retinopathy Screening Technology Across Portable and Tabletop Devices Demonstrates 99% Imageability, One-Image-per-Eye Workflow, and Best-in-Class Diagnostic Efficacy